Credo Technology shares surge 14.83% after-hours on Q2 earnings beat and AI-driven demand, with revenue tripling and raised guidance.
ByAinvest
Tuesday, Dec 2, 2025 4:02 pm ET1min read
CRDO--
Credo Technology surged 14.83% in after-hours trading, driven by a combination of strong Q2 earnings, robust revenue growth, and analyst upgrades. The company reported a 272% year-over-year revenue increase to $268 million, fueled by heightened demand for AI infrastructure and its active electrical cables. Earnings beat estimates, with adjusted EPS of $0.67, and guidance for Q3 revenue of $335–$345 million exceeded expectations. Analysts upgraded price targets and maintained "buy" ratings, citing Credo’s leadership in AI-driven data center solutions and expansion into high-growth segments like ZeroFlap Optics. The stock’s rally aligns with broader investor enthusiasm.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet